Xlife Sciences AG
Develops and commercializes early-stage life sciences research projects.
XLS | SW
Overview
Corporate Details
- ISIN(s):
- CH0461929603 (+1 more)
- LEI:
- 984500AH590BE88BB517
- Country:
- Switzerland
- Address:
- Talacker 35, 8001 Zürich
Description
Xlife Sciences AG is a life sciences company that specializes in the value development and commercialization of early-stage research projects. The company identifies promising technologies from universities and other research institutions, acting as an incubator and accelerator to bridge the gap between academic research and healthcare markets. Its operations are focused on four core areas: technology platforms, biotechnologies and therapies, medical technology (health technology), and the application of artificial intelligence in life sciences and digital health. The primary objective is to develop solutions that address high unmet medical needs and improve quality of life.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2024-09-19 02:00 |
Xlife Sciences AG: Erfolgreiches erstes Halbjahr 2024 mit strategischen Fortsch…
|
German | HTML • 10.9 KB | ||
| 2024-09-03 07:00 |
Xlife Sciences AG Completes Strategic Review Process by Q3 2024
|
English | HTML • 6.2 KB | ||
| 2024-09-03 02:00 |
Xlife Sciences AG Completes Strategic Review Process by Q3 2024
|
English | HTML • 4.7 KB | ||
| 2024-09-03 02:00 |
Xlife Sciences AG schließt den strategischen Reviewprozess per Q3 2024 ab
|
German | HTML • 6.9 KB | ||
| 2024-06-28 18:00 |
Xlife Sciences AG: Successful General Assembly and New Trading Hours on the Spa…
|
English | HTML • 9.5 KB | ||
| 2024-06-28 02:00 |
Xlife Sciences AG: Successful General Assembly and New Trading Hours on the Spa…
|
English | HTML • 7.7 KB | ||
| 2024-06-28 02:00 |
Xlife Sciences AG: Erfolgreiche Generalversammlung und neue Handelszeiten am Sp…
|
German | HTML • 8.3 KB | ||
| 2024-06-26 07:00 |
Xlife Sciences AG Reports Success in Liver Diagnostics x-nuclear diagnostics G…
|
English | HTML • 9.7 KB | ||
| 2024-06-26 02:00 |
Xlife Sciences AG Reports Success in Liver Diagnostics – x-nuclear diagnostics …
|
English | HTML • 7.9 KB | ||
| 2024-06-26 02:00 |
Xlife Sciences AG meldet Erfolg in der Leberdiagnostik – x-nuclear diagnostics …
|
German | HTML • 8.6 KB | ||
| 2024-05-27 07:00 |
Xlife Sciences AG Announces Strategic Merger Between palleos healthcare GmbH an…
|
English | HTML • 12.8 KB | ||
| 2024-05-27 02:00 |
Xlife Sciences AG Announces Strategic Merger Between palleos healthcare GmbH an…
|
English | HTML • 10.8 KB | ||
| 2024-05-27 02:00 |
Xlife Sciences AG gibt strategischen Zusammenschluss zwischen palleos healthcar…
|
German | HTML • 11.8 KB | ||
| 2024-04-30 07:00 |
Xlife Sciences AG Reports Strong Portfolio Growth and Strategic Advances in the…
|
English | HTML • 7.0 KB | ||
| 2024-04-30 02:00 |
Xlife Sciences AG Reports Strong Portfolio Growth and Strategic Advances in the…
|
English | HTML • 5.5 KB |
Automate Your Workflow. Get a real-time feed of all Xlife Sciences AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Xlife Sciences AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Xlife Sciences AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-06-15 | N/A | Executive member | Buy | None | 6,000.00 CHF |
| 2022-06-15 | N/A | Executive member | Buy | None | 3,000.00 CHF |
| 2022-06-14 | N/A | Executive member | Buy | None | 15,500.00 CHF |
| 2022-06-10 | N/A | Executive member | Buy | None | 6,728.90 CHF |
| 2022-06-07 | N/A | Executive member | Buy | None | 34,800.00 CHF |
| 2022-06-03 | N/A | Executive member | Buy | None | 3,540.00 CHF |
| 2022-05-24 | N/A | Executive member | Buy | None | 3,400.00 CHF |
| 2022-05-17 | N/A | Executive member | Buy | None | 10,794.20 CHF |
| 2022-05-13 | N/A | Executive member | Buy | None | 3,690.00 CHF |
| 2022-05-10 | N/A | Executive member | Buy | None | 1,935.00 CHF |
Peer Companies
